182 related articles for article (PubMed ID: 8300133)
1. Idiotypic cascades after MAb OC125 application.
Reinsberg J
Hybridoma; 1993 Oct; 12(5):577-82. PubMed ID: 8300133
[No Abstract] [Full Text] [Related]
2. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network.
Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782
[TBL] [Abstract][Full Text] [Related]
3. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
Wagner U; Reinsberg J; Krebs D
Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
Wagner UA; Oehr PF; Reinsberg J; Schmidt SC; Schlebusch HW; Schultes B; Werner A; Prietl G; Krebs D
Biotechnol Ther; 1992; 3(1-2):81-9. PubMed ID: 1305894
[TBL] [Abstract][Full Text] [Related]
6. Antitumor antibodies for immunotherapy of ovarian carcinomas.
Wagner U
Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
[No Abstract] [Full Text] [Related]
7. Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin.
Klug TL; Green PJ; Zurawski VR; Davis HM
Clin Chem; 1988 Jun; 34(6):1071-6. PubMed ID: 2454168
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic manipulation of the antibody response to a retrovirus-induced tumor.
Powell TJ; Lamon EW
Prog Clin Biol Res; 1989; 288():289-93. PubMed ID: 2785691
[No Abstract] [Full Text] [Related]
9. Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibody.
Maher VE; Drukman SJ; Kinders RJ; Hunter RE; Jennings J; Brigham C; Stevens S; Griffin TW
J Immunother (1991); 1992 Jan; 11(1):56-66. PubMed ID: 1734949
[TBL] [Abstract][Full Text] [Related]
10. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Ross AH; Iliopoulos D; Koprowski H
Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13.
Baum RP; Noujaim AA; Nanci A; Moebus V; Hertel A; Niesen A; Donnerstag B; Sykes T; Boniface G; Hör G
Hybridoma; 1993 Oct; 12(5):583-9. PubMed ID: 8300134
[No Abstract] [Full Text] [Related]
12. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
Reinsberg J; Krebs D
Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
[TBL] [Abstract][Full Text] [Related]
13. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody.
Reinsberg J; Nocke W
Eur J Clin Chem Clin Biochem; 1993 May; 31(5):323-7. PubMed ID: 8357942
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.
Austin EB; Robins RA; Durrant LG; Price MR; Baldwin RW
Immunology; 1989 Aug; 67(4):525-30. PubMed ID: 2788611
[TBL] [Abstract][Full Text] [Related]
15. Useful and not-so-useful idiotypic images.
Köhler H; Raychaudhuri S
Prog Clin Biol Res; 1989; 288():223-33. PubMed ID: 2470109
[No Abstract] [Full Text] [Related]
16. Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma.
Glennie MJ; Stevenson GT
Adv Exp Med Biol; 1985; 186():843-53. PubMed ID: 3876727
[No Abstract] [Full Text] [Related]
17. [Generation of genetic engineering anti-idiotypic antibody against OC125 monoclonal antibody of ovarian carcinoma].
Zhang X; Cui H; Qian H
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):646-8. PubMed ID: 9387521
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies and idiotypic network activation for ovarian carcinoma.
Wagner U; Reinsberg J; Schmidt S; Mallmann P; Schmolling J; Schultes B; Richter H; Biersack HJ; Krebs D
Cell Biophys; 1994; 24-25():237-42. PubMed ID: 7736528
[TBL] [Abstract][Full Text] [Related]
20. Human antiidiotypic antibodies against OC125 strongly interfere with one-step assays of CA 125 employing OC125 and M11 antibodies.
Reinsberg J; Gast B
Clin Chem; 1994 Jun; 40(6):951-2. PubMed ID: 8087996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
